EchoNous, which markets a compact, AI-powered ultrasound software, has raised $57 million.
The funding was famous in a current regulatory submitting and confirmed by a spokesperson. The Redmond, Wash.-based startup expects to lift a further $15 million by the tip of September as a part of the Sequence D spherical, mentioned the spokesperson.
The money comes on the heels of a $60 million increase in June 2021. That funding helped gas the business launch of the corporate’s flagship gadget, Kosmos, an AI-guided point-of-care ultrasound system that may picture the center and different areas of the physique.
The corporate’s deep studying algorithms assist operators gather high-quality pictures, label them, and mechanically calculate key measurements like the center’s ejection fraction. The corporate says Kosmos supplies diagnostic-quality pictures that rival these from bulkier, much less transportable and costlier units.
Kosmos was not too long ago rated extremely for total picture high quality in an unbiased research evaluating 5 completely different hand-held ultrasound units.
The brand new funding will likely be used for product improvement and AI coaching and integration with the platform. The funding may also propel expertise improvement of its Lexsa ultrasound probe, which obtained “510(okay)” clearance final 12 months from the U.S. Meals and Drug Administration, labelling it as “considerably equal” to current units. The probe permits Kosmos to carry out nerve, lung, vascular and mucoskeletal ultrasound on the bedside.
EchoNous, launched in 2015, additionally not too long ago signed a partnership with Samsung that can allow healthcare suppliers to pair Kosmos with a Samsung pill.
EchoNous CEO Kevin Goodwin was beforehand CEO of ultrasound gadget developer Sonosite, which bought in 2011 to Fujifilm for $995 million. EchoNous has about 150 staff.
The brand new fairness funding spherical was led by Kennedy Lewis Funding Administration.